Events
-
ENDO 2026: Women’s thyroid cancer risk may be linked to reproductive lifespan and hormone therapy
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: CAPTURE trial delivers learnings for metastatic breast cancer treatment
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
-
-
Delay in breast cancer operations appears non-life-threatening for early-stage disease
A new breast cancer study brings reassuring findings for women with early-stage breast cancer who…
State first MR-Linac: GenesisCare launches NSW-first adaptive radiation therapy technology for patients with prostate and oligometastatic cancer
GenesisCare at St Vincent’s Hospital in Darlinghurst has become the first oncology service in NSW…
A normal DNA repair process can become a major source of mutations in cancer
Hypermutation is an unusual occurence that can lead to many nearby mutations at once, severely…
Voices of patients and oncologists must be heard, study says
Specifically training oncologists and their patients to have high-quality discussions improves communication, but troubling gaps still exist between the two…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.